IRCT20190810044500N7招募中2 期
Evaluation of Levamisole efficacy and safety in combination with routine therapy in patients with Covid-19: a clinical trial
Yazd University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Ages 18 to 60 years
- •Diagnosis of Covid-19 over the past 24 hours
- •Female patients are not exposed to pregnancy and do not become pregnant until thirty days later.
- •Not taking levamisole for the past five days (due to 16-hour drug half-life)
- •Patients suspected to covid-19 based on clinical signs and symptoms of CT scan and candidate for outpatient treatment
- •No medication other than protocol
- •No underlying disease
排除标准
- •Hospitalized Patients
- •Patients with hemodynamic instability
- •History of cirrhosis, hepatitis and severe liver disease, severe renal failure (less than 30ml / min)
- •Patients currently taking levamisole for other uses such as parasitic infection
- •Patients with a history of allergic reaction or sensitivity to levamisole
- •Patients receiving chemotherapy for cancer
- •Pregnancy and lactation
- •Ages less than 18 years and over 60 years
- •Patients with underlying diseases including diabetes and hypertension
研究者
相似试验
已完成
3 期
Efficacy of Levamisol in Treating COVID-19IRCT20201124049480N1Artesh University of Medical Sciences365
已完成
3 期
The role of levamisole co-administration hepatitis B vaccine in immunization.eed for immunization against viral hepatitis.Persons with potential health hazards related to communicable diseasesIRCT2014110618915N2Mashad University of Medical Sciences217
进行中（未招募）
1 期
AEUCTR2016-002324-92-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)156
已完成
2 期
Effect of levamisole adjuvant plus hepatitis B vaccine in vaccine non-responders health care workersHepatitis B vaccination.Need for immunization against viral hepatitisIRCT2014012110417N3Kermanshah University of Medical Sciences40
尚未招募
4 期
Efficacy And Safety of Levamisole in African Children With Nephrotic Syndrome: A Protocol For A Double-Blinded, Standard of Care-Controlled Randomized Trial (ESOLAC TRIAL)PaediatricsKidney DiseasePACTR202201750782433The Molecular Pathology Institute72